Claudia Carella

Olaparib as maintenance therapy in patients with BRCA 1–2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome

Sabrina Chiara Cecere, Gaia Giannone, Vanda Salutari et al. · Gynecologic Oncology · 2019 · 106 citations · Full text

Medicine, Gynecology, Oncology +16

First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin

Roberto Iacovelli, Chiara Ciccarese, Matteo Brunelli et al. · Annals of Oncology · 2022 · 24 citations

Medicine, Oncology, Pharmacotherapy +12

Standardization of CTC AR‐V7 PCR assay and evaluation of its role in castration resistant prostate cancer progression

Stefania Tommasi, Brunella Pilato, Claudia Carella et al. · The Prostate · 2018 · 23 citations

Medicine, Oncology, Pharmacology +17

Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial

Francesca Vignani, Rosa Tambaro, Ugo De Giorgi et al. · European Urology · 2022 · 22 citations

Medicine, Oncology, Pharmacology +13

Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a)

Marco Stellato, Sebastiano Buti, Marco Maruzzo et al. · International Journal of Molecular Sciences · 2023 · 19 citations · Full text

Medicine, Oncology, Pharmacology +16